Check it out now to enjoy watching an interview with Dr. Kevin Kalinsky from Winship Cancer Institute of Emory University to have a sneak peek of his lecture “Gene assay tools to inform chemotherapy benefit in HR+ HER2- anatomically high risk early breast cancer”

*Interviewer:
Dr. Jiun-I Lai/Taipei Veterans General Hospital